O'Neil Thomas P. 4
4 · Satsuma Pharmaceuticals, Inc. · Filed Aug 7, 2020
Insider Transaction Report
Form 4
O'Neil Thomas P.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock, $0.0001 par value
2020-08-05$4.56/sh+1,000$4,560→ 1,000 total - Sale
Common Stock, $0.0001 par value
2020-08-05$25.00/sh−1,000$25,000→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-08-05−1,000→ 66,340 totalExercise: $4.56Exp: 2029-05-16→ Common Stock (1,000 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The option vest and become exercisable in successive, equal monthly installments over four years measured from May 15, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.